Quanterix Corporation (QTRX) Operating Margin
- Operating margin · 12 months: Value -99.65%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -99.65% | Operating income / revenue. Period ending 2026-06-30. $-152.87M ÷ $153.41M × 100 ≈ -99.65% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -152.87M USD | Operating Income (Loss) |
| Revenue | 153.41M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 31.95M USD | Research and Development Expense |
| Selling, general and administration | 133.61M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-152.87M | $153.41M | (m) | $31.95M | $133.61M | -99.65% |
| 2026-03-31 | $-140.54M | $144.98M | (m) | $33.21M | $136.61M | -96.94% |
| 2025-12-31 | $-125.54M | $138.90M | (m) | $35.92M | $138.01M | -90.38% |
| 2025-09-30 | $-115.56M | $130.20M | (m) | $35.19M | $131.46M | -88.75% |
| 2025-06-30 | $-89.98M | $125.78M | (m) | $35.29M | $115.31M | -71.54% |
| 2025-03-31 | $-63.83M | $135.69M | (m) | $34.38M | $108.04M | -47.04% |
| 2024-12-31 | $-52.62M | $137.42M | (m) | $31.08M | $101.62M | -38.29% |
| 2024-09-30 | $-51.46M | $133.81M | (m) | $30.23M | (m) | -38.46% |
| 2024-06-30 | $-57.79M | $129.33M | (m) | $28.97M | $97.93M | -44.69% |
| 2024-03-31 | $-54.25M | $125.98M | (m) | $26.81M | $95.38M | -43.06% |
| 2023-12-31 | $-49.70M | $122.37M | (m) | $24.86M | $90.24M | -40.62% |
| 2023-09-30 | $-54.71M | $116.64M | (m) | $23.47M | $85.34M | -46.90% |
| 2023-06-30 | $-77.54M | $111.95M | (m) | $22.90M | $81.71M | -69.26% |
| 2023-03-31 | $-92.94M | $104.43M | (m) | $23.58M | $87.17M | -89.00% |
| 2022-12-31 | $-101.70M | $105.52M | (m) | $25.89M | $92.00M | -96.38% |
| 2022-09-30 | $-99.64M | $109.98M | (m) | $28.02M | $101.15M | -90.60% |
| 2022-06-30 | $-78.28M | $111.03M | (m) | $28.20M | $104.85M | -70.50% |
| 2022-03-31 | $-66.98M | $112.90M | (m) | $28.33M | $98.59M | -59.33% |
| 2021-12-31 | $-58.59M | $110.56M | (m) | $27.98M | $92.34M | -52.99% |
| 2021-09-30 | $-48.62M | $106.40M | (m) | $26.46M | $82.68M | -45.70% |
| 2021-06-30 | $-31.11M | $110.10M | (m) | $25.03M | $72.46M | -28.26% |
| 2021-03-31 | $-29.64M | $97.86M | (m) | $22.59M | $64.77M | -30.29% |
| 2020-12-31 | $-31.58M | $86.38M | (m) | $20.17M | $59.59M | -36.57% |
| 2020-09-30 | $-33.13M | $76.16M | (m) | $18.36M | $54.78M | -43.50% |
| 2020-06-30 | $-45.66M | $59.72M | (m) | $16.90M | $54.68M | -76.45% |
| 2020-03-31 | $-43.97M | $60.12M | (m) | $16.61M | $55.01M | -73.13% |
| 2019-12-31 | $-41.60M | $56.73M | (m) | $16.19M | $52.25M | -73.32% |
| 2019-09-30 | $-39.53M | $51.69M | (m) | $15.84M | $48.87M | -76.47% |
| 2019-06-30 | $-36.95M | $47.34M | (m) | $16.32M | $44.36M | -78.05% |
| 2019-03-31 | $-33.74M | $42.45M | (m) | $16.01M | $38.51M | -79.49% |
| 2018-12-31 | $-31.55M | $37.63M | (m) | $15.80M | $33.69M | -83.84% |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $-26.00M | $22.87M | (m) | $16.30M | $19.69M | -113.69% |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $-21.71M | $17.59M | (m) | $16.99M | $12.47M | -123.46% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |